Holen Sie sich die Stockscreener-App
311.57
4.78%
14.22
Schlusskurs vom Vortag:
$297.35
Offen:
$295.67
24-Stunden-Volumen:
841.65K
Relative Volume:
0.64
Marktkapitalisierung:
$50.45B
Einnahmen:
$3.32B
Nettoeinkommen (Verlust:
$941.65M
KGV:
55.48
EPS:
5.6161
Netto-Cashflow:
$1.64B
1W Leistung:
+9.38%
1M Leistung:
+16.86%
6M Leistung:
+86.23%
1J Leistung:
+8.42%
1-Tages-Spanne:
$295.67
$311.72
1-Wochen-Bereich:
$284.00
$309.32
52-Wochen-Spanne:
$148.05
$311.72
Veeva Systems Inc Stock (VEEV) Company Profile
Firmenname
Veeva Systems Inc
Sektor
Branche
Telefon
925-452-6500
Adresse
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs TEM, BTSG, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
311.57 | 50.45B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
70.02 | 12.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.86 | 12.44B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
104.99 | 8.47B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.58 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-24 | Fortgesetzt | Piper Sandler | Overweight |
| 2026-07-23 | Eingeleitet | Guggenheim | Buy |
| 2026-04-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2026-02-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2026-01-13 | Fortgesetzt | Goldman | Sell |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-12 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-07 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-09-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-29 | Bestätigt | Needham | Buy |
| 2025-01-23 | Herabstufung | Goldman | Buy → Sell |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-08-27 | Bestätigt | Citigroup | Buy |
| 2024-07-09 | Eingeleitet | BTIG Research | Buy |
| 2023-10-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Truist | Buy → Hold |
| 2023-02-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Eingeleitet | Cowen | Market Perform |
| 2022-12-02 | Bestätigt | Needham | Buy |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | Goldman | Buy |
| 2022-06-21 | Fortgesetzt | Guggenheim | Buy |
| 2022-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2022-01-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Fortgesetzt | Stifel | Buy |
| 2021-09-02 | Bestätigt | BofA Securities | Buy |
| 2021-09-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-09-02 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Eingeleitet | Cowen | Outperform |
| 2021-03-31 | Hochstufung | UBS | Sell → Neutral |
| 2021-01-07 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Fortgesetzt | UBS | Sell |
| 2020-08-28 | Bestätigt | Needham | Buy |
| 2020-07-23 | Eingeleitet | FBN Securities | Outperform |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-06-08 | Eingeleitet | Citigroup | Buy |
| 2020-05-29 | Bestätigt | Needham | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-14 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Bestätigt | Canaccord Genuity | Hold |
| 2019-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Bestätigt | Needham | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Neutral |
| 2019-05-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-27 | Bestätigt | Needham | Buy |
Alle ansehen
Veeva Systems Inc Aktie (VEEV) Neueste Nachrichten
iOnctura appoints Paul Sekhri as Chair of its Board of Directors - GlobeNewswire Inc.
VEEV Expands IQVIA Partnership With Clinical Operations Software Suite - Zacks Investment Research
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today - Benzinga
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo! Finance Canada
Veeva Systems (VEEV) Increases Despite Market Slip: Here's What You Need to Know - Zacks Investment Research
Veeva Systems (VEEV) Stock Trades Up, Here Is Why - Yahoo Finance
Seilern Investment Management Ltd Sells 138,217 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems stock hits 52-week high at 302.87 USD - Investing.com
Veeva Systems (NYSE:VEEV) Hits New 12-Month HighHere's What Happened - MarketBeat
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - TradingView
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
IQVIA Selects Veeva Systems Clinical Operations Applications - marketscreener.com
IQVIA Selects Veeva Clinical Operations Applications – Company Announcement - Financial Times
Form 4 Veeva Systems Inc For: 12 October By Investing.com - Investing.com Nigeria
Form 4 Veeva Systems Inc For: 12 October By Investing.com - Investing.com Canada
Veeva Systems’ (VEEV) Comeback Gets Jim Cramer Talking - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Veeva Systems (NYSE:VEEV) Upgraded to Buy at Wall Street Zen - MarketBeat
Veeva Systems Inc (VEEV) Stock Up 4.0% but GF Value Says Overval - GuruFocus
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Vilga Financial Planning LLC Purchases 6,000 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.
Bell Asset Management Ltd Decreases Stock Position in Veeva Systems Inc. $VEEV - MarketBeat
5,900 Shares in Veeva Systems Inc. $VEEV Acquired by Westwind Capital - MarketBeat
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality - Yahoo Finance
Wealth Enhancement Trust Services Inc. Buys 3,933 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Veeva Systems Announces More Than 175 Emerging Biotechs Standardize On Veeva Basics To Accelerate Drug Development - marketscreener.com
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - Zacks Investment Research
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - TradingView
Veeva Systems Announces Veeva DQS Cleans Data For More Than 1 Million Subjects Across Over 1,000 Studies - marketscreener.com
Sites and sponsors saved thousands of hours on trial data cleanup with Veeva. - Stock Titan
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now? - Zacks Investment Research
ETFs Investing in Veeva Systems Inc. Class A Stocks - TradingView
Veeva Systems Inc (VEEV) Shares Surge 3.7% -- What GF Score of 99 Tells Investors - GuruFocus
Veeva Systems (NYSE:VEEV) EVP Daniel Rizzo Sells 4,841 Shares of Company Stock - MarketBeat
Veeva Systems (VEEV) withholds 705 shares for taxes as its CFO converts stock grants. - Stock Titan
For taxes, Veeva Systems (VEEV) withholds 1,272 shares from Schwenger’s stock award conversion. - Stock Titan
After 854 shares were withheld for taxes, Veeva Systems (VEEV) EVP Rizzo sold 4,520 and 321 shares. - Stock Titan
Accounting chief acquires 168 Veeva Systems (VEEV) shares; 61 are withheld for taxes. - Stock Titan
Following a $9.01M August sale, a former officer proposes another at Veeva Systems (NYSE: VEEV). - Stock Titan
Rockland Trust Co. Reduces Holdings in Veeva Systems Inc. $VEEV - MarketBeat
43,000 Veeva Systems Inc. $VEEV Shares Sold by Bright Rock Capital Management LLC - MarketBeat
Veeva's OpenData to Help Servier Build a Global AI Data Foundation - TradingView
Company News for Oct 5, 2026 - Zacks Investment Research
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo! Finance Canada
Veeva Systems Inc. (VEEV) stock price, news, quote and history - Yahoo Finance Australia
Veeva Systems Inc (VEEV) Stock Down 3.0% -- Now Undervalued? GF Score: 99/100 - GuruFocus
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Finanzdaten der Veeva Systems Inc-Aktie (VEEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veeva Systems Inc-Aktie (VEEV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Faddis Jonathan | Officer |
Oct 14 '26 |
Proposed Sale |
299.72 |
5,198 |
1,557,920 |
0 |
| THOMAS SCHWENGER | Former Officer |
Oct 05 '26 |
Proposed Sale |
279.73 |
132,751 |
37,134,887 |
0 |
| Rizzo Daniel J | EVP, Sales, Consulting, & Svcs |
Oct 02 '26 |
Sale |
276.51 |
4,841 |
1,338,578 |
7,665 |
| DANIEL RIZZO | Officer |
Oct 02 '26 |
Proposed Sale |
276.51 |
4,841 |
1,338,578 |
0 |
| Kondath Vipin | Chief Accounting Officer |
Oct 01 '26 |
Option Exercise |
0.00 |
168 |
0 |
2,951 |
| Faddis Jonathan | SVP, Gen. Counsel, Secretary |
Oct 01 '26 |
Option Exercise |
0.00 |
1,636 |
0 |
10,964 |
| Van Wagener Brian | Chief Financial Officer |
Oct 01 '26 |
Option Exercise |
0.00 |
1,636 |
0 |
10,961 |
| Zuppas Eleni Nitsa | President & Chief of Staff |
Oct 01 '26 |
Option Exercise |
0.00 |
2,181 |
0 |
35,599 |
| Rizzo Daniel J | EVP, Sales, Consulting, & Svcs |
Oct 01 '26 |
Option Exercise |
0.00 |
1,672 |
0 |
13,360 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer |
Oct 01 '26 |
Option Exercise |
0.00 |
2,907 |
0 |
21,356 |
2.61%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):